In order to qualify for treatment with GLP-1 medications, patients must have a BMI of 30 or above, which is classified as obesity.

It may also be considered for those with a BMI of 27 or above if they have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol. Patients who have a BMI between 27-30 will be required to complete labs before their appointment.